Company: VRCA
Filing Date: 2025-12-15
Form Type: S-3
Source: 0001193125-25-319225
Chunk: 15

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-12-15
Form: S-3
Chunk 15
---
 (a) 707,338 shares of our common stock                                                                                                                                            
 issued to Affinity Healthcare Fund, LP (“Affinity”) in the Private Placement and (b) 176,834 shares of our common stock issuable upon exercise of Common Warrants issued to Affinity in the Private Placement. Affinity Asset Advisors, LLC 
 (“AAALLC”) is the investment manager of Affinity and has voting and investment power over the shares held by Affinity. The business address of AAALLC and Affinity is 450 Park Avenue, Suite 1403, New York, New York 10022.                |

| (12) | “Beneficial Ownership Prior to this Offering” consists of (a) 471,559 shares of our common stock                                                                                                                                    
 issued to Velan Capital Master Fund LP (“Velan”) in the Private Placement and (b) 117,889 shares of our common stock issuable upon exercise of Common Warrants issued to Velan in the Private Placement. Velan Capital Holdings LLC 
 (“Velan GP”) is the general partner of Velan and may be deemed to beneficially own the shares beneficially owned by Velan. Velan Capital Investment Management LP (“Velan Capital”) is the investment manager of Velan and may be   
 deemed to beneficially own the shares beneficially owned by Velan. Velan Capital Management LLC (“Velan IM GP”) is the general partner of Velan Capital and may                                                                     |

9

| be deemed to beneficially own the shares beneficially owned by Velan. Balaji Venkataraman is a Managing Member of each of Velan GP and Velan IM GP and may be deemed to beneficially own the shares                                                   
 beneficially owned by Velan. Adam Morgan is a Managing Member of each of Velan GP and Velan IM GP and may be deemed to beneficially own the shares beneficially owned by Velan. The address of Velan is 100 North Main Street, Suite 301, Alpharetta, 
 Georgia, 30009.                                                                                                                                                                                                                                       |

| (13) | “Beneficial Ownership Prior to this Offering” consists of (a) 353,669 shares of our common stock                                                                                                                                             
 issued to Stonepine Capital, LP (“Stonepine”) in the Private Placement and (b) 88,417 shares of our common stock issuable upon exercise of Common Warrants issued to Stonepine in the Private Placement. Jon M. Plexico exercises voting and 
 investment discretion with respect to these securities and as